- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Michael Kolodziej Discusses Taking on 2-Sided Risk in OCM After PP4 Results
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., discusses the move to 2-sided risk in the Oncology Care Model (OCM).
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., discusses the move to 2-sided risk in the Oncology Care Model (OCM).
Transcript
We're at a transformative time now with the OCM, with performance period 4 results out now with some practices having to either take on 2-sided risk or leave the model. What's the mindset of these practices right now?
You’d have to ask them. So, in general, I think physicians are risk averse. I think it’s pretty clear, and this is based on what [Center for Medicare and Medicaid Innovation] has told us, that a quarter of the practices aren’t close. Those guys are just going to quit. I think for the 35% or so of practices that are on the cusp, the question becomes if you do the math: I get the [Monthly Enhanced Oncology Services], I get the 5% bonus because of the advanced [alternative payment model], how far away am I and how can I manage that risk? And at least the scuttlebutt is that a lot of practices are engaging insurers to protect them from catastrophic loss.
So, they’re buying insurance against a bad outcome, which is not a bad idea because of the fact that we don’t know what therapies are going to come out in the next 5 years. We don’t know what the case mix is likely going to be in the next 5 years, and those are variables we cannot control. So even if you’ve done splendidly until this point, there’s still going to be risk going forward.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
